Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Titel:
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Auteur:
Khoury, H. Jean Cortes, Jorge E. Kantarjian, Hagop M. Gambacorti-Passerini, Carlo Baccarani, Michele Kim, Dong-Wook Zaritskey, Andrey Countouriotis, Athena Besson, Nadine Leip, Eric Kelly, Virginia Brümmendorf, Tim H.